Hematology
Feature
Worldwide trial seeks to revolutionize pediatric leukemia care
Leukemia & Lymphoma Society project offers free genomic screening, plus access to subtrials.
From the Journals
Children born from frozen embryos may have increased cancer risk
The results, however, “should be interpreted cautiously,” the authors noted, given the low number of cancer cases reported among children born...
Latest News
Children with sickle cell anemia not getting treatments, screening
Annual screenings are recommended as is treatment with hydroxyurea, but only about half of affected children are getting lifesaving care.
Latest News
AAP guidance helps distinguish bleeding disorders from abuse
Laboratory testing of bleeding cannot always rule out abuse, just as a history of trauma may not rule out a bleeding disorder or other medical...
Latest News
Newborns get routine heel blood tests, but should states keep those samples?
Some states allow the blood spots to be used in research studies, sometimes by third parties for a fee, or provided to law enforcement personnel...
Conference Coverage
Blood test for multiple cancers: Many false positives
“This technology is not ready for population-wide screening, but as the technology improves, costs will go down.”
News
Blood type linked to higher risk for early onset stroke
“The risk of stroke due to blood type is smaller than other risk factors that we know about, like smoking and hypertension. I would be much more...
News
First drug therapy approved for childhood GVHD
FDA greenlights ibrutinib for child blood cancer patients with chronic graft-versus-host disease.
From the Journals
Blood biomarkers predict TBI disability and mortality
Measuring glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase L1 proteins may give a more accurate assessment of a patient’s...
Latest News
Leukemia rates two to three times higher in children born near fracking
“This study is among the few to focus on drinking water specifically and the first to apply a novel metric designed to capture potential exposure...
News from the FDA/CDC
FDA approves first gene therapy, betibeglogene autotemcel (Zynteglo), for beta-thalassemia
The one-time gene therapy represents a potential cure in which functional copies of the mutated gene are inserted into patients’ hematopoietic...